Medical Patent News

RSS

Wyeth and Impax settle Effexor XR patent case

Wyeth and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax's proposed generic capsule formulation of Wyeth's Effexor XR antidepressant have been approved by the United States District Court for the District of Delaware.

17 Jul 2008

Drugs industry protecting 'morally unacceptable' patent system

Major drugs companies are using fierce lobbying tactics to protect a pharmaceutical patent system that is "simply morally unacceptable", a world-leading political philosopher will tell a major meeting of UK and European pharmacologists today (Thursday 17 July 2008).

From The University of Manchester 16 Jul 2008

Stem Cell Sciences granted UK patent for new growth medium for authentic embryonic stem cells

Stem Cell Sciences plc today announced that the UK Patent Office has granted it a patent covering the Company's new range of stem cell culture media. The new Culticell iSTEM range uses the inhibitor based technology discovered by Professor Austin Smith and recently published in Nature (vol. 453, pp.519-523).

8 Jul 2008

Brazilian organization files opposition to Gilead's antiretroviral patent application in India

The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science's antiretroviral drug Tenofovir, saying that the patent would have a direct impact on Brazil's ability to produce and access affordable generic versions of the drug, India's Business Standard reports. Opponents of the patent say that the drug consists of a previously known compound and, therefore, cannot be patented under India's Patents Act.

2 Jul 2008

Bavarian Nordic files patent infringement suit against Oxford BioMedica

Bavarian Nordic has filed a patent infringement suit against Oxford BioMedica plc, Biomedica, Inc., and Oxford BioMedica Ltd., in the United States District Court of the Southern District of California.

30 Jun 2008

Barr announces favorable ruling in Mirapex patent challenge

Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.

26 Jun 2008

Clinical Data secures European patent for key multi-drug resistance gene

Clinical Data, Inc. has announced that the European Patent Office has granted Patent No. 1232260 to Bernried, Germany-based Epidauros Biotechnologie AG, a wholly-owned subsidiary of Clinical Data, relating to the use of a genetic variant, or biomarker, of the gene MDR1 (also known as ABCB1), which encodes P-glycoprotein (PGP).

26 Jun 2008

Aventix Pharma takes over key patents for innovative screening tool for treatments for cystic fibrosis

The rights to key patents for an innovative screening tool for treatments for cystic fibrosis were transferred today to Swiss biotech company Axentis Pharma AG.

26 Jun 2008

India's patent office rejects Boehringer's application for pediatric antiretroviral

India's Patent Office in New Delhi earlier this month rejected German drug maker Boehringer Ingelheim's application for a pediatric version of the antiretroviral drug nevirapine, consequently allowing local generic pharmaceutical companies such as Aurobindo and Cipla to continue marketing low-cost versions of the medicine in the domestic market, the Business Standard reports.

24 Jun 2008

Alchemia granted first two patents in the "Synthetic Heparin Oligosaccharide" family of patents

Alchemia Ltd. has announced the granting of the first two patents in the "Synthetic Heparin Oligosaccharide" family of patents.

23 Jun 2008

AutoGenomics issued European patent for Human papillomavirus

AutoGenomics has announced that it has been issued a key European patent for Human papillomavirus.

19 Jun 2008

Ranbaxy and Pfizer settle on Lipitor patent litigation

Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine.

19 Jun 2008

Peregrine Pharmaceuticals awarded two new U.S. patents for targeted anti-aminophospholipid agents

Peregrine Pharmaceuticals, Inc. today reported the issuance of two U.S. patents that significantly broaden the company's intellectual property leadership in the field of targeted anti-aminophospholipid agents.

16 Jun 2008

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.

16 Jun 2008

Breakthrough in understanding tumor immune therapy

Researchers from the Tubingen University, Department of Dermatology, uncovered an entirely new understanding on how the immune system may control tumor development.

11 Jun 2008

EntreMed receives new patent for 2-Methoxyestradiol analogs

EntreMed, Inc. has announced the issuance of U.S. Patent No. 7,371,741 covering analogs of 2- methoxyestradiol (2ME2).

11 Jun 2008

Mylan wins generic Prilosec patent litigation

Mylan Inc. has announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a May 2007 District Court ruling stating that Mylan's 10 mg and 20 mg Omeprazole delayed-release capsules do not infringe patents asserted against Mylan by AstraZeneca.

11 Jun 2008

Barr confirms patent challenge of Prevacid SoluTab tablets

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by TAP Pharmaceuticals Inc. in connection with its Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets (lansoprazole), 15mg and 30mg.

11 Jun 2008

Telik announces patents on TELINTRA compounds

Telik, Inc. announced today that the European Patent Office has issued notices of allowance for two applications covering new compounds related to one of Telik's lead clinical candidates, TELINTRA.

11 Jun 2008

FDA grants pediatric exclusivity for UCB's Keppra

UCB has announced that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Keppra (levetiracetam). The decision was based on pediatric data submitted to the FDA following a written request in 2001.

8 Jun 2008

Medical Patent News

Wyeth and Impax settle Effexor XR patent case

Drugs industry protecting 'morally unacceptable' patent system

Stem Cell Sciences granted UK patent for new growth medium for authentic embryonic stem cells

Brazilian organization files opposition to Gilead's antiretroviral patent application in India

Bavarian Nordic files patent infringement suit against Oxford BioMedica

Barr announces favorable ruling in Mirapex patent challenge

Clinical Data secures European patent for key multi-drug resistance gene

Aventix Pharma takes over key patents for innovative screening tool for treatments for cystic fibrosis

India's patent office rejects Boehringer's application for pediatric antiretroviral

Alchemia granted first two patents in the "Synthetic Heparin Oligosaccharide" family of patents

AutoGenomics issued European patent for Human papillomavirus

Ranbaxy and Pfizer settle on Lipitor patent litigation

Peregrine Pharmaceuticals awarded two new U.S. patents for targeted anti-aminophospholipid agents

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

Breakthrough in understanding tumor immune therapy

EntreMed receives new patent for 2-Methoxyestradiol analogs

Mylan wins generic Prilosec patent litigation

Barr confirms patent challenge of Prevacid SoluTab tablets

Telik announces patents on TELINTRA compounds

FDA grants pediatric exclusivity for UCB's Keppra

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News